Chemsex and chemsex associated substance use among men who have sex with men in Asia: A systematic review and meta-analysis.

Haoyi Wang, Kai J Jonas, Thomas E Guadamuz
Author Information
  1. Haoyi Wang: Department of Work and Social Psychology, Maastricht University, Maastricht, the Netherlands. Electronic address: haoyi.wang@maastrichtuniveristy.nl.
  2. Kai J Jonas: Department of Work and Social Psychology, Maastricht University, Maastricht, the Netherlands. Electronic address: kai.jonas@maastrichtuniversity.nl.
  3. Thomas E Guadamuz: Faculty of Social Sciences and Humanities, Mahidol University, Nakorn Pathom, Thailand; John F. Kennedy School of Government, Harvard University, Cambridge, MA, USA. Electronic address: thomas.gua@mahidol.edu.

Abstract

BACKGROUND: The prevalence of chemsex has been reported by multiple systematic reviews among men who have sex with men (MSM) focussing predominantly on the Global North. An Asian perspective with meta-analytical evidence is missing. This meta-analysis summarised the prevalence of substance use associated with chemsex, and chemsex activity among MSM and MSM sub-populations in Asia, as well as the likelihood for chemsex among MSM living with or without HIV.
METHODS: We utilized PubMed, Web of Science and medRxiv to search for literature describing chemsex and its associated substance use among MSM and MSM sub-populations in Asia from January 1, 2010 to November 1, 2021 to conduct three meta-analyses with both frequentist and Bayesian approaches.
RESULTS: We identified 219 studies and included 23 in the meta-analysis. Based on the frequentist models, methamphetamine was the default substance associated with chemsex among MSM in Asia (prevalence = 0.16, 95 %CI:0.09-0.22), followed by GHB/GBL (prevalence = 0.15, 95 %CI:0.03-0.27) and ketamine (prevalence = 0.08, 95 %CI:0.04-0.12), but hardly any cocaine (prevalence = 0.01, 95 %CI:0.00-0.03). Compared to a general MSM population (prevalence = 0.19, 95 %CI:0.15-0.23), MSM engaging in transactional sex showed a higher prevalence of chemsex (MSM sex work clients [prevalence = 0.28, 95 %CI:0.11-0.45]; MSM sex worker [prevalence = 0.28, 95 %CI:0.17-0.26]). MSM living with HIV also showed higher odds of chemsex activity (OR = 3.35, 95 %CI:1.57-7.10), compared to MSM living without HIV. Both meta-analytic models converged, indicating robust evidence.
CONCLUSIONS: Our meta-analyses showed that chemsex is not uncommon among MSM, and MSM engaging in transactional sex in Asia. We confirmed that MSM living with HIV have a higher likelihood of engaging in chemsex, too. Chemsex prevention and management strategies in Asia should be adjusted accordingly.

Keywords

References

  1. AIDS Behav. 2016 Dec;20(Suppl 3):386-397 [PMID: 27553027]
  2. Subst Use Misuse. 2018 Sep 19;53(11):1907-1914 [PMID: 29461132]
  3. Drug Alcohol Depend. 2014 May 1;138:146-53 [PMID: 24629628]
  4. Int J Drug Policy. 2015 Aug;26(8):755-63 [PMID: 26003930]
  5. Ann Intern Med. 2015 Jun 2;162(11):777-84 [PMID: 26030634]
  6. Arch Sex Behav. 2021 Feb;50(2):427-460 [PMID: 33108566]
  7. J Med Internet Res. 2020 Jul 24;22(7):e17894 [PMID: 32706705]
  8. Sex Transm Infect. 2015 Dec;91(8):564-8 [PMID: 26163510]
  9. Drug Test Anal. 2021 Jan;13(1):227-234 [PMID: 33140585]
  10. Sex Transm Dis. 2018 May;45(5):325-331 [PMID: 29465683]
  11. Int J Drug Policy. 2018 May;55:256-262 [PMID: 29605540]
  12. Int J STD AIDS. 2016 Mar;27(3):196-206 [PMID: 25792548]
  13. J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):331-335 [PMID: 32282444]
  14. Eur J Pharmacol. 2020 May 15;875:173012 [PMID: 32087255]
  15. Int J Drug Policy. 2019 Jan;63:74-89 [PMID: 30513473]
  16. AIDS Care. 2012;24(2):210-9 [PMID: 21780964]
  17. Sex Transm Infect. 2019 Feb;95(1):67-70 [PMID: 29535222]
  18. Int J Drug Policy. 2016 Dec;38:4-12 [PMID: 27788450]
  19. PLoS One. 2013 Dec 10;8(12):e81960 [PMID: 24339982]
  20. Perspect Public Health. 2019 Jan;139(1):23-33 [PMID: 29846139]
  21. BMC Infect Dis. 2020 Apr 22;20(1):299 [PMID: 32321442]
  22. AIDS Care. 2013;25(10):1236-44 [PMID: 23394142]
  23. Int J Drug Policy. 2021 Jul;93:103187 [PMID: 33771421]
  24. Public Health. 2016 Nov;140:213-220 [PMID: 27381058]
  25. BMC Infect Dis. 2018 Apr 17;18(1):182 [PMID: 29665785]
  26. J Urban Health. 2005 Mar;82(1 Suppl 1):i62-70 [PMID: 15738319]
  27. AIDS Behav. 2017 Apr;21(4):1105-1116 [PMID: 27351193]
  28. Sex Transm Dis. 2012 Apr;39(4):251-2 [PMID: 22421689]
  29. J Acquir Immune Defic Syndr. 2007 May 1;45(1):85-92 [PMID: 17325605]
  30. Sex Transm Infect. 2019 Aug;95(5):342-350 [PMID: 30979782]
  31. Drug Alcohol Depend. 2015 Jun 1;151:31-7 [PMID: 25865907]
  32. Front Psychiatry. 2020 Nov 23;11:612192 [PMID: 33329162]
  33. Int J Environ Res Public Health. 2020 Dec 04;17(23): [PMID: 33291855]
  34. Subst Use Misuse. 2017 Sep 19;52(11):1411-1419 [PMID: 28436758]
  35. AIDS Care. 2021 Aug;33(8):1098-1106 [PMID: 33258694]
  36. Drug Alcohol Depend. 2012 Jan 1;120(1-3):246-9 [PMID: 21831535]
  37. Res Synth Methods. 2017 Mar;8(1):79-91 [PMID: 27362487]
  38. J Sex Med. 2019 May;16(5):721-732 [PMID: 30952548]
  39. Lancet HIV. 2018 Jul;5(7):e379-e389 [PMID: 29861202]
  40. Eur Addict Res. 2021;27(3):161-178 [PMID: 33279895]
  41. BMC Public Health. 2021 May 31;21(1):1026 [PMID: 34059021]
  42. J Subst Abuse Treat. 2017 Sep;80:26-32 [PMID: 28755769]
  43. Sex Transm Dis. 2020 Jun;47(6):e15 [PMID: 32413020]
  44. Int J Drug Policy. 2018 May;55:131-148 [PMID: 29625796]
  45. J Clin Epidemiol. 2015 Jan;68(1):52-60 [PMID: 25304503]
  46. PLoS One. 2014 May 06;9(5):e95675 [PMID: 24802357]
  47. BMC Infect Dis. 2014 Dec 02;14:642 [PMID: 25443542]
  48. AIDS Behav. 2018 Jul;22(7):2161-2171 [PMID: 28612212]
  49. J Int AIDS Soc. 2021 Nov;24(11):e25841 [PMID: 34797952]
  50. Liver Int. 2020 Sep;40(9):2104-2109 [PMID: 32574394]
  51. BMC Public Health. 2021 Feb 15;21(1):354 [PMID: 33588816]
  52. Int J Drug Policy. 2020 Jan;75:102591 [PMID: 31756695]
  53. Postgrad Med J. 2014 Mar;90(1061):133-8 [PMID: 24390619]
  54. Drug Alcohol Depend. 2021 Mar 1;220:108516 [PMID: 33485009]
  55. Biomed Res Int. 2014;2014:725361 [PMID: 24829916]
  56. JMIR Public Health Surveill. 2019 Jul 03;5(3):e13083 [PMID: 31271148]
  57. Arch Sex Behav. 2012 Oct;41(5):1273-82 [PMID: 22392516]

Grants

  1. R01 MH119015/NIMH NIH HHS
  2. R21 AI140939/NIAID NIH HHS

MeSH Term

Male
Humans
Homosexuality, Male
Unsafe Sex
Illicit Drugs
Bayes Theorem
Sexual and Gender Minorities
Cross-Sectional Studies
Substance-Related Disorders
Asia
HIV Infections
Sexual Behavior

Chemicals

Illicit Drugs

Word Cloud

Created with Highcharts 10.0.0MSMchemsexprevalence=95amongsex0%CI:0AsiaHIVmensubstanceuseassociatedlivingmeta-analysisengagingshowedhigherChemsexsystematicevidenceactivitysub-populationslikelihoodwithout1meta-analysesfrequentist23modelstransactional[prevalence28BACKGROUND:reportedmultiplereviewsfocussingpredominantlyGlobalNorthAsianperspectivemeta-analyticalmissingsummarisedwellMETHODS:utilizedPubMedWebSciencemedRxivsearchliteraturedescribingJanuary2010November2021conductthreeBayesianapproachesRESULTS:identified219studiesincludedBasedmethamphetaminedefault1609-022followedGHB/GBL1503-027ketamine0804-012hardlycocaine0100-003Comparedgeneralpopulation1915-0workclients11-045]worker17-026]alsooddsOR335%CI:157-710comparedmeta-analyticconvergedindicatingrobustCONCLUSIONS:uncommonconfirmedpreventionmanagementstrategiesadjustedaccordinglyAsia:reviewMeta-analysisSubstanceTransactional

Similar Articles

Cited By